Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

NXL

Nexalin Technology Inc

Last Close
Jun 14 • 04:00PM ET
0.8992
Dollar change
-0.4811
Percentage change
-34.85 		%
Scroll to Statements
Index- P/E- EPS (ttm)-0.67 Insider Own20.67% Shs Outstand7.44M Perf Week24.89%
Market Cap6.69M Forward P/E- EPS next Y- Insider Trans0.20% Shs Float5.90M Perf Month-33.88%
Income-4.94M PEG- EPS next Q- Inst Own0.85% Short Float1.03% Perf Quarter90.91%
Sales0.16M P/S41.81 EPS this Y- Inst Trans- Short Ratio0.09 Perf Half Y124.74%
Book/sh0.31 P/B2.87 EPS next Y- ROA-112.76% Short Interest0.06M Perf Year2.18%
Cash/sh0.29 P/C3.13 EPS next 5Y- ROE-139.94% 52W Range0.25 - 3.40 Perf YTD122.13%
Dividend Est.- P/FCF- EPS past 5Y2.43% ROI-212.35% 52W High-73.55% Beta5.35
Dividend TTM- Quick Ratio4.75 Sales past 5Y175.50% Gross Margin-808.19% 52W Low255.70% ATR (14)0.22
Dividend Ex-DateMar 23, 2007 Current Ratio5.05 EPS Y/Y TTM-136.94% Oper. Margin-3770.98% RSI (14)47.95 Volatility56.60% 23.80%
Employees6 Debt/Eq0.00 Sales Y/Y TTM-84.56% Profit Margin-3110.57% Recom- Target Price-
Option/ShortNo / No LT Debt/Eq0.00 EPS Q/Q-36.32% Payout- Rel Volume5.63 Prev Close1.38
Sales Surprise- EPS Surprise- Sales Q/Q157.43% Earnings- Avg Volume686.16K Price0.90
SMA20-0.65% SMA50-33.96% SMA20034.66% Trades Volume3,860,182 Change-34.85%
Jun-14-24 09:00AM
Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
(ACCESSWIRE) -34.85%
08:21AM
Why Is Nexalin Technology (NXL) Stock Down 29% Today?
(InvestorPlace)
07:30AM
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
(InvestorPlace)
Jun-13-24 03:00PM
Nexalin Technology Announces Regulatory Approval to Sell Nexalin's Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)
(GlobeNewswire) +125.10%
Jun-06-24 07:00AM
MicroCap Rodeo's Spring into Summer Conference, June 6th 2024 - 25 Presenting Companies
(ACCESSWIRE) +8.67%
08:30AM Loading…
Jun-04-24 08:30AM
Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th
(GlobeNewswire)
Jun-03-24 08:30AM
FDA Provides Feedback and Reaches Consensus on Nexalin's Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity Headset Device
(GlobeNewswire)
May-30-24 07:47AM
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
(InvestorPlace) +7.37%
May-22-24 08:30AM
Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts
(GlobeNewswire)
May-13-24 10:54AM
NXL Stock Earnings: Nexalin Technology Reported Results for Q1 2024
(InvestorPlace)
May-09-24 08:30AM
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on May 23
(GlobeNewswire)
Apr-25-24 10:44AM
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
(GlobeNewswire)
Apr-10-24 08:30AM
Nexalin Technology CEO Provides Letter to Shareholders
(GlobeNewswire)
Apr-09-24 08:30AM
Nexalin Technology Accelerates Manufacturing of its HALO Clarity Following Successful Usability, Feasibility, and Electrical Testing
(GlobeNewswire)
Apr-04-24 01:00PM
Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity , a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
(GlobeNewswire) -10.42%
11:05AM Loading…
11:05AM
Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device
(News Direct)
Apr-02-24 08:30AM
Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board
(GlobeNewswire) +51.05%
Mar-28-24 08:30AM
Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego
(GlobeNewswire) +79.49%
Mar-14-24 08:30AM
Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin's Technology
(GlobeNewswire) +20.00%
Mar-13-24 08:30AM
Nexalin Technology Announces Poster Presentation at State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment
(GlobeNewswire) +8.17%
Mar-06-24 08:30AM
Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia
(GlobeNewswire) +49.55%
Feb-08-24 08:30AM
Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device
(GlobeNewswire)
Jan-23-24 08:30AM
Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System
(GlobeNewswire)
Jan-11-24 08:30AM
Nexalin Technology Unveils Next-Generation HALO Clarity
(GlobeNewswire) +9.67%
Dec-18-23 08:30AM
Nexalin Technology Reports Significant Positive Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device on Treatment-Resistant Depression
(GlobeNewswire)
Oct-25-23 08:30AM
Nexalin Technology Announces Formation of New Military & Government Advisory Board to be Led by Government Affairs Veteran David Lasseter
(GlobeNewswire) +19.30%
Oct-16-23 08:30AM
Nexalin Technology Announces Publication of Groundbreaking Deep-Brain Stimulation Study in Leading Peer-Reviewed Journal; Validates the Ability of Nexalin's Neurostimulation Device to Penetrate Deep Brain Structures
(GlobeNewswire) -28.92%
Aug-07-23 08:30AM
Nexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related Symptoms
(GlobeNewswire)
Aug-03-23 08:30AM
Nexalins CEO Mark White to be Interviewed Live on The Big Biz Show Today at 3PM Eastern Time
(GlobeNewswire)
Jul-26-23 08:30AM
Nexalin Technology Announces New Public Sector Division to Capitalize on Opportunities to Serve U.S. Government Agencies
(GlobeNewswire)
08:30AM Loading…
Jul-10-23 08:30AM
Nexalin Technology Announces Abstract Accepted for Presentation at 2023 Military Health System Research Symposium Validating the Potential of its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Mild Traumatic Brain Injury
(GlobeNewswire)
Jun-01-23 08:30AM
Nexalin Technology, Inc. and Wider Come Limited Announce Joint Venture Agreement to Advance Commercialization of Nexalins tACS Devices in the Asia Pacific Region
(GlobeNewswire) +7.24%
Mar-30-23 06:33AM
Nexalin Technology Full Year 2022 Earnings: US$0.30 loss per share (vs US$1.43 loss in FY 2021)
(Simply Wall St.)
Mar-27-23 07:00AM
Nexalin Technology Provides 2022 Year-End Business Update
(GlobeNewswire) -18.03%
Jan-24-23 08:30AM
Nexalin Technology Appoints Medical Device Veteran Michael Nketiah as Senior Vice President of Quality, Clinical and Regulatory
(GlobeNewswire)
Jan-05-23 08:30AM
Nexalin Technology CEO Provides Letter to Shareholders
(GlobeNewswire)
Nov-14-22 02:00PM
Nexalin Technology Announces Publication of a White Paper Validating its tACS Device for the Treatment of Generalized Anxiety Disorder
(GlobeNewswire)
Sep-20-22 01:12PM
Nexalin Technology, Inc. Announces Closing of $9.6 Million Initial Public Offering
(GlobeNewswire) -5.33%
Sep-15-22 08:54PM
Nexalin Technology, Inc. Announces Pricing of $9.6 Million Initial Public Offering
(GlobeNewswire)
Apr-10-22 06:52PM
What Kind Of Investors Own Most Of Nuix Limited (ASX:NXL)?
(Simply Wall St.)
Nexalin Technology, Inc. designs and develops neurostimulation products. Its medical devices helps people with mental health illness. The company was founded by John Patrick Claude on October 19, 2010 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Owens DavidChief Medical OfficerJun 10 '24Buy0.643,0001,920144,174Jun 12 01:19 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.